feed,title,long_url,short_url
GN:S:RL,"Insilico leverages its proprietary AI-driven platforms to effectively address the challenges of identifying accurate targets, developing novel molecular structures with desired parameters, and predicting clinical trial outcomes. - The Killeen Daily Herald",https://kdhnews.com/news/texas/insilico-leverages-its-proprietary-ai-driven-platforms-to-effectively-address-the-challenges-of-identifying-accurate/image_32af8e8f-d74b-55b8-994c-ef3a677e7072.html,https://bit.ly/3GZjfmt
